MDM4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.008400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.853600E-01
Normal-vs-Stage2
5.086600E-01
Normal-vs-Stage3
3.950000E-01
Normal-vs-Stage4
5.268200E-01
Stage1-vs-Stage2
5.083600E-01
Stage1-vs-Stage3
1.151590E-01
Stage1-vs-Stage4
5.825600E-01
Stage2-vs-Stage3
1.700580E-01
Stage2-vs-Stage4
8.839000E-01
Stage3-vs-Stage4
1.592970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.064200E-01
Normal-vs-AfricanAmerican
4.726000E-01
Normal-vs-Asian
4.690400E-01
Caucasian-vs-AfricanAmerican
6.437000E-01
Caucasian-vs-Asian
4.857200E-01
AfricanAmerican-vs-Asian
9.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.140600E-01
Normal-vs-Female
4.870800E-01
Male-vs-Female
3.215200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.076600E-01
Normal-vs-Age(41-60Yrs)
5.142400E-01
Normal-vs-Age(61-80Yrs)
4.983800E-01
Normal-vs-Age(81-100Yrs)
4.742400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.841800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.914800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.670000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.628600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.562600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.627400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.291600E-01
Normal-vs-Daily Drinker
4.595000E-01
Normal-vs-Weekly Drinker
4.880400E-01
Normal-vs-Occasional Drinker
5.163000E-01
Normal-vs-Social Drinker
5.147000E-01
Non Drinker-vs-Daily Drinker
1.527810E-01
Non Drinker-vs-Weekly Drinker
5.411800E-01
Non Drinker-vs-Occasional Drinker
8.345400E-01
Non Drinker-vs-Social Drinker
8.209400E-01
Daily Drinker-vs-Weekly Drinker
6.270800E-01
Daily Drinker-vs-Occasional Drinker
2.727400E-01
Daily Drinker-vs-Social Drinker
2.451000E-01
Weekly Drinker-vs-Occasional Drinker
6.838200E-01
Weekly Drinker-vs-Social Drinker
6.824600E-01
Occasional Drinker-vs-Social Drinker
9.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.184400E-02
Normal-vs-Grade 2
7.898700E-03
Normal-vs-Grade 3
1.613610E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.239600E-01
Grade 1-vs-Grade 3
9.822800E-01
Grade 1-vs-Grade 4
9.184400E-02
Grade 2-vs-Grade 3
8.466000E-01
Grade 2-vs-Grade 4
7.898700E-03
Grade 3-vs-Grade 4
1.613610E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.019200E-01
Normal-vs-NonDiabetic
4.982400E-01
Diabetic-vs-NonDiabetic
9.438800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.835600E-01
Normal-vs-NoPancreatitis
4.969200E-01
Pancreatitis-vs-NoPancreatitis
6.754000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.111000E-01
Normal-vs-N1
4.987600E-01
N0-vs-N1
7.003400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.890800E-01
Normal-vs-TP53-NonMutant
5.625000E-01
TP53-Mutant-vs-TP53-NonMutant
7.349600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
